Senate Concurrent ResolutionNo. 8


Introduced by Senator Fuller

January 13, 2015


Senate Concurrent Resolution No. 8—Relative to X-linked adrenoleukodystrophy.

LEGISLATIVE COUNSEL’S DIGEST

SCR 8, as introduced, Fuller. Adrenoleukodystrophy Awareness Month.

This measure would memorialize the month of November 2015 as Adrenoleukodystrophy Awareness Month.

Fiscal committee: no.

P1    1WHEREAS, X-linked adrenoleukodystrophy (X-ALD) is one
2of a group of genetic disorders called the leukodystrophies that
3cause damage to the myelin sheath, an insulating membrane that
4surrounds nerve cells in the brain; and

5WHEREAS, Women have two X chromosomes and are the
6carriers of the disease, but men are most severely affected because
7men only have one X chromosome and lack the protection provided
8by an extra X chromosome; and

9WHEREAS, The loss of myelin and the progressive dysfunction
10of the adrenal gland are the primary characteristics of X-ALD; and

11WHEREAS, X-ALD affects an estimated one in every 20,000
12boys, which is roughly 13,600 people in the United States,
13including boys like Jeremy Hill, Jr. of Bakersfield; and

14WHEREAS, While nearly all patients with X-ALD suffer from
15adrenal insufficiency, also known as Addison’s disease, the
16neurological symptoms can begin either in childhood or adulthood;
17and

P2    1WHEREAS, The childhood cerebral form is the most severe,
2with onset between ages four and 10; and

3WHEREAS, The most common symptoms are behavioral
4changes, including abnormal withdrawal or aggression, poor
5memory, and poor school performance; and

6WHEREAS, Other symptoms include visual loss, learning
7disabilities, seizures, poorly articulated speech, difficulty
8swallowing, deafness, disturbances of gait and coordination,
9fatigue, intermittent vomiting, increased skin pigmentation, and
10progressive dementia; and

11WHEREAS, The milder adult-onset form is known as
12adrenomyeloneuropathy (AMN), which typically begins between
1321 and 35 years of age, and has symptoms that include progressive
14stiffness, weakness or paralysis of the lower limbs, and ataxia; and

15WHEREAS, Almost one-half the women who are carriers of
16X-ALD will develop a milder form of AMN, but almost never will
17develop symptoms seen in boys with X-ALD; and

18WHEREAS, Treatment with adrenal hormones can be lifesaving,
19and symptomatic and supportive treatments for X-ALD include
20physical therapy, psychological support, and special education;
21and

22WHEREAS, Newborn screening is effective in catching and
23preventing the negative effects of X-ALD and is relatively
24inexpensive; and

25WHEREAS, The prognosis for patients with childhood cerebral
26X-ALD is generally poor due to progressive neurological
27deterioration, unless bone marrow transplantation is performed
28early; and

29WHEREAS, Recent evidence suggests that a mixture of oleic
30acid and erucic acid, known as “Lorenzo’s Oil,” administered to
31boys with X-ALD prior to the onset of symptoms can prevent or
32delay, but not stop, the appearance of the childhood cerebral form
33of X-ALD; and

34WHEREAS, Death usually occurs between one and 10 years
35after the onset of symptoms of childhood cerebral X-ALD, and in
36adult-onset AMN deterioration will progress over decades; and

37WHEREAS, November, the month of Jeremy Hill, Jr.’s birthday,
38was chosen to acknowledge the struggles of Jeremy Hill, Jr., his
39parents, Jeremy and Debra Hill, and his sister, Meagan Hill, in
40fighting X-ALD; now, therefore, be it

P3    1Resolved by the Senate of the State of California, the Assembly
2thereof concurring,
That the Legislature does hereby proclaim the
3month of November 2015 as Adrenoleukodystrophy Awareness
4Month; and be it further

5Resolved, That the Secretary of the Senate transmit copies of
6this resolution to the author for appropriate distribution.



O

    99